![Mark Williams](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Williams
President chez
MARVEL BIOSCIENCES CORP.
Fortune : 586 887 $ au 31/05/2026
Profil
Mark Williams is the founder of Sanomune, Inc. Dr. Williams is President, Director & Chief Science Officer at Marvel Biosciences Corp.
since 2021.
Dr. Williams is Director at Grey Matters Health, Inc. since 2021.
Dr. Williams was Director & Chief Science Officer at First Responder Technologies, Inc. from 2019 to 2020.
Dr. Williams was Vice President-Research at DiaMedica Therapeutics, Inc. from 2010 to 2016.
Dr. Williams was Vice President-Research at Cerebra Health, Inc. from 2016 to 2018.
Dr. Williams was President & Chief Scientific Officer at Alphanco Venture Corp.
Dr. Williams was Chief Scientific Officer at Grey Matters Health, Inc. from 2018 to 2021.
Dr. Williams earned a doctorate from the University of Alberta.
Dr. Williams earned an MBA from the University of Manitoba.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 29/12/2025 | 5 000 049 ( 7,93% ) | 575 006 $ | 31/05/2026 | |
| 31/07/2025 | 37 480 ( 0,69% ) | 11 881 $ | 31/05/2026 |
Postes actifs de Mark Williams
| Sociétés | Poste | Début |
|---|---|---|
| MARVEL BIOSCIENCES CORP. | President | 14/06/2021 |
| GREY MATTERS HEALTH INC. | Directeur/Membre du Conseil | 16/09/2021 |
Anciens postes connus de Mark Williams
| Sociétés | Poste | Fin |
|---|---|---|
| GREY MATTERS HEALTH INC. | Directeur Technique/Scientifique/R&D | 01/03/2021 |
| QUEBEC HOLDINGS PEGMATITE | Directeur Technique/Scientifique/R&D | 30/09/2020 |
Cerebra Health, Inc. | Directeur Technique/Scientifique/R&D | 01/01/2018 |
| DIAMEDICA THERAPEUTICS INC. | Directeur Technique/Scientifique/R&D | 28/11/2016 |
| ALPHANCO VEN | President | - |
Formation de Mark Williams
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
25
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
DiaMedica Therapeutics, Inc.
 DiaMedica Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of therapeutic treatments from novel recombinant proteins | Health Technology |
University of Alberta
 University of Alberta Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Manitoba
 University of Manitoba Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanomune, Inc.
 Sanomune, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes biopharmaceutical products | Health Technology |
Algernon Pharmaceuticals, Inc.
 Algernon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage, drug development and repurposing company | Health Technology |
Cerebra Health, Inc. | |
First Responder Technologies, Inc.
 First Responder Technologies, Inc. Aerospace & DefenseElectronic Technology Manufactures weapon detection devices | Electronic Technology |
Alphanco Venture Corp.
 Alphanco Venture Corp. Financial ConglomeratesFinance Engages in the identification of potential acquisitions | Finance |
Marvel Biosciences Corp.
 Marvel Biosciences Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Choisissez Zonebourse 
